Browse the corpus

Walk the Even Hospital Database by book and chapter — the raw source passages that ground Ask, DDx, and the rest.

2 passages

referencesuptodate· REFERENCES· item f35_49_36633

REFERENCES Kent HL. Epidemiology of vaginitis. Am J Obstet Gynecol 1991; 165:1168. Foxman B, Marsh JV, Gillespie B, Sobel JD. Frequency and response to vaginal symptoms among white and African American women: results of a random digit dialing survey. J Womens Health 1998; 7:1167. Landers DV, Wiesenfeld HC, Heine RP, et al. Predictive value of the clinical diagnosis of lower genital tract infection in women. Am J Obstet Gynecol 2004; 190:1004. Sobel JD. Vulvovaginitis in healthy women. Compr Ther 1999; 25:335. Anderson MR, Klink K, Cohrssen A. Evaluation of vaginal complaints. JAMA 2004; 291:1368. Allen-Davis JT, Beck A, Parker R, et al. Assessment of vulvovaginal complaints: accuracy of telephone triage and in-office diagnosis. Obstet Gynecol 2002; 99:18. Carr PL, Rothberg MB, Friedman RH, et al. "Shotgun" versus sequential testing. Cost-effectiveness of diagnostic strategies for vaginitis. J Gen Intern Med 2005; 20:793. Sobel JD. Erosive Vulvovaginitis. Curr Infect Dis Rep 2003; 5:494. Lamont RF, Sobel JD, Akins RA, et al. The vaginal microbiome: new information about genital tract flora using molecular based techniques. BJOG 2011; 118:533. Hull T, Hilber AM, Chersich MF, et al. Prevalence, motivations, and adverse effects of vaginal practices in Africa and Asia: findings from a multicountry household survey. J Womens Health (Larchmt) 2011; 20:1097. Zantomio D, Grigg AP, MacGregor L, et al. Female genital tract graft-versus-host disease: incidence, risk factors and recommendations for management. Bone Marrow Transplant 2006; 38:567. Spiryda LB, Laufer MR, Soiffer RJ, Antin JA. Graft-versus-host disease of the vulva and/or vagina: diagnosis and treatment. Biol Blood Marrow Transplant 2003; 9:760. Kaser DJ, Reichman DE, Laufer MR. Prevention of vulvovaginal sequelae in stevens-johnson syndrome and toxic epidermal necrolysis. Rev Obstet Gynecol 2011; 4:81. Cibley LJ, Cibley LJ. Cytolytic vaginosis. Am J Obstet Gynecol 1991; 165:1245. Cerikcioglu N, Beksac MS. Cytolytic vaginosis: misdiagnosed as candidal vaginitis. Infect Dis Obstet Gynecol 2004; 12:13. Mead PB, Winn WC. Vaginal-rectal colonization with group A streptococci in late pregnancy. Infect Dis Obstet Gynecol 2000; 8:217. Bray S, Morgan J. Two cases of group A streptococcal vulvovaginitis in premenopausal adults in a sexual health setting. Sex Health 2006; 3:187.

referencesuptodate· REFERENCES· item f35_49_36633

Cerikcioglu N, Beksac MS. Cytolytic vaginosis: misdiagnosed as candidal vaginitis. Infect Dis Obstet Gynecol 2004; 12:13. Mead PB, Winn WC. Vaginal-rectal colonization with group A streptococci in late pregnancy. Infect Dis Obstet Gynecol 2000; 8:217. Bray S, Morgan J. Two cases of group A streptococcal vulvovaginitis in premenopausal adults in a sexual health setting. Sex Health 2006; 3:187. Sobel JD, Funaro D, Kaplan EL. Recurrent group A streptococcal vulvovaginitis in adult women: family epidemiology. Clin Infect Dis 2007; 44:e43. Subramanian C, Nyirjesy P, Sobel JD. Genital malodor in women: a modern reappraisal. J Low Genit Tract Dis 2012; 16:49. Begum M, McKenna PJ. Olfactory reference syndrome: a systematic review of the world literature. Psychol Med 2011; 41:453. Grimley DM, Annang L, Foushee HR, et al. Vaginal douches and other feminine hygiene products: women's practices and perceptions of product safety. Matern Child Health J 2006; 10:303. Hassan S, Chatwani A, Brovender H, et al. Douching for perceived vaginal odor with no infectious cause of vaginitis: a randomized controlled trial. J Low Genit Tract Dis 2011; 15:128. Leclair CM, Hart AE, Goetsch MF, et al. Group B streptococcus: prevalence in a non-obstetric population. J Low Genit Tract Dis 2010; 14:162. Rein MF. Current therapy of vulvovaginitis. Sex Transm Dis 1981; 8:316. duBouchet L, Spence MR, Rein MF, et al. Multicenter comparison of clotrimazole vaginal tablets, oral metronidazole, and vaginal suppositories containing sulfanilamide, aminacrine hydrochloride, and allantoin in the treatment of symptomatic trichomoniasis. Sex Transm Dis 1997; 24:156. Topic 5477 Version 24.0 © 2013 UpToDate, Inc. All rights reserved. | Subscription and License Agreement | Release: 21.4 - C21.36 Licensed to: Southeast Alabama Med Ctr | Support Tag: [0505-197.136.42.3-0869272E05-S244013.14]